Ray Dalio Eli Lilly & CO Transaction History

Bridgewater Associates, LP

$19.6 Billion
Q1 2024

A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Eli Lilly & CO stock. As of the latest transaction made, Bridgewater Associates, LP holds 280,386 shares of LLY stock, worth $216 Million. This represents 1.11% of its overall portfolio holdings.

Number of Shares

280,386

Previous 317,586 11.71%

Holding current value

$216 Million

Previous $185 Million 17.83%

% of portfolio

1.11%

Previous 1.04%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $22 Million - $29.5 Million	-37,200 Reduced 11.71%	280,386 $218 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $134 Million - $158 Million	255,619 Added 412.51%	317,586 $185 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $22.6 Million - $31.1 Million	-51,918 Reduced 45.59%	61,967 $33.3 Million
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $51 Million - $68.2 Million	-145,381 Reduced 56.07%	113,885 $53.4 Million
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $8.86 Million - $10.4 Million	28,528 Added 12.36%	259,266 $89 Million

Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $18.7 Million - $21.8 Million	-58,115 Reduced 20.12%	230,738 $84.4 Million
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $24.9 Million - $28.4 Million	84,028 Added 41.02%	288,853 $93.4 Million
Q2 2022 Aug 11, 2022	SELL	$278.73 - $327.27 $11.9 Million - $13.9 Million	-42,521 Reduced 17.19%	204,825 $66.4 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $29.2 Million - $36.2 Million	124,227 Added 100.9%	247,346 $70.8 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $17.3 Million - $21.4 Million	76,737 Added 165.45%	123,119 $34 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $4.5 Million - $5.54 Million	20,316 Added 77.94%	46,382 $10.7 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $4.71 Million - $6.09 Million	26,066 New	26,066 $5.98 Million
Q2 2020 Aug 12, 2020	SELL	$136.42 - $164.18 $3.92 Million - $4.72 Million	-28,770 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$119.05 - $147.35 $3.43 Million - $4.24 Million	28,770 New	28,770 $3.99 Million
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $869,794 - $1.08 Million	-8,135 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $868,736 - $944,961	8,135 New	8,135 $910,000
Q4 2018 Feb 13, 2019	SELL	$105.9 - $118.64 $14.3 Million - $16.1 Million	-135,421 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $7.82 Million - $9.78 Million	-91,104 Reduced 40.22%	135,421 $14.5 Million
Q2 2018 Aug 13, 2018	BUY	$75.7 - $86.88 $55,033 - $63,161	727 Added 0.32%	226,525 $0
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $7.56 Million - $8.92 Million	101,858 Added 82.18%	225,798 $17.5 Million
Q4 2017 Feb 13, 2018	BUY	$81.94 - $87.89 $10.2 Million - $10.9 Million	123,940	123,940 $10.5 Million

Others Institutions Holding LLY

# of Institutions

3,703

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $732B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track Ray Dalio's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Account